These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


547 related items for PubMed ID: 25707991

  • 1. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.
    Kaufman AC, Salazar SV, Haas LT, Yang J, Kostylev MA, Jeng AT, Robinson SA, Gunther EC, van Dyck CH, Nygaard HB, Strittmatter SM.
    Ann Neurol; 2015 Jun; 77(6):953-71. PubMed ID: 25707991
    [Abstract] [Full Text] [Related]

  • 2. The Fyn kinase inhibitor, AZD0530, suppresses mouse alcohol self-administration and seeking.
    Morisot N, Berger AL, Phamluong K, Cross A, Ron D.
    Addict Biol; 2019 Nov; 24(6):1227-1234. PubMed ID: 30536923
    [Abstract] [Full Text] [Related]

  • 3. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model.
    Smith LM, Zhu R, Strittmatter SM.
    Neuropharmacology; 2018 Mar 01; 130():54-61. PubMed ID: 29191754
    [Abstract] [Full Text] [Related]

  • 4. Panaxadiol inhibits synaptic dysfunction in Alzheimer's disease and targets the Fyn protein in APP/PS1 mice and APP-SH-SY5Y cells.
    Liang X, Yao Y, Lin Y, Kong L, Xiao H, Shi Y, Yang J.
    Life Sci; 2019 Mar 15; 221():35-46. PubMed ID: 30735733
    [Abstract] [Full Text] [Related]

  • 5. In Vivo Synaptic Density Imaging with 11C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease.
    Toyonaga T, Smith LM, Finnema SJ, Gallezot JD, Naganawa M, Bini J, Mulnix T, Cai Z, Ropchan J, Huang Y, Strittmatter SM, Carson RE.
    J Nucl Med; 2019 Dec 15; 60(12):1780-1786. PubMed ID: 31101744
    [Abstract] [Full Text] [Related]

  • 6. Targeting Fyn Kinase in Alzheimer's Disease.
    Nygaard HB.
    Biol Psychiatry; 2018 Feb 15; 83(4):369-376. PubMed ID: 28709498
    [Abstract] [Full Text] [Related]

  • 7. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy.
    Tang SJ, Fesharaki-Zadeh A, Takahashi H, Nies SH, Smith LM, Luo A, Chyung A, Chiasseu M, Strittmatter SM.
    Acta Neuropathol Commun; 2020 Jul 01; 8(1):96. PubMed ID: 32611392
    [Abstract] [Full Text] [Related]

  • 8. Anti-PrPC antibody rescues cognition and synapses in transgenic alzheimer mice.
    Cox TO, Gunther EC, Brody AH, Chiasseu MT, Stoner A, Smith LM, Haas LT, Hammersley J, Rees G, Dosanjh B, Groves M, Gardener M, Dobson C, Vaughan T, Chessell I, Billinton A, Strittmatter SM.
    Ann Clin Transl Neurol; 2019 Mar 01; 6(3):554-574. PubMed ID: 30911579
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
    Salazar SV, Cox TO, Lee S, Brody AH, Chyung AS, Haas LT, Strittmatter SM.
    J Neurosci; 2019 Jan 23; 39(4):758-772. PubMed ID: 30518596
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, Yin XP, Wang W.
    Behav Brain Res; 2016 Sep 15; 311():309-321. PubMed ID: 27233830
    [Abstract] [Full Text] [Related]

  • 14. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X, Liang Z, Li Y, Zhi Y, Yi L, Bai S, Forest KH, Nichols RA, Dong Y, Li QX.
    Behav Brain Res; 2021 Feb 01; 398():112968. PubMed ID: 33069740
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J, Wang JX, Du YH, Liu Y, Zhang W, Chen JF, Liu YJ, Zheng M, Wang KJ, He GQ.
    CNS Neurosci Ther; 2018 Dec 01; 24(12):1207-1218. PubMed ID: 29869390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.